Management of skin cancer in solid organ transplant recipients

Dermatologic Therapy

Volumn 18, Issue 1, 2005, Pages 12-18

  Traywick, Carmen ^a   O'Reilly, Fiona M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Metastasis; Multidisciplinary patient care; Skin cancer; Solid organ transplant

Indexed keywords

ACTINIC KERATOSIS; CARCINOGENESIS; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KAPOSI SARCOMA; KERATOACANTHOMA; MELANOMA; MERKEL CELL TUMOR; ORGAN TRANSPLANTATION; PATIENT EDUCATION; POSTOPERATIVE PERIOD; PREVALENCE; RECIPIENT; REVIEW; RISK FACTOR; SCREENING; SKIN CANCER; SKIN DEFECT; T CELL LYMPHOMA;

HUMANS; IMMUNOSUPPRESSIVE AGENTS; ORGAN TRANSPLANTATION; SKIN NEOPLASMS;

EID: 18844424574     PISSN: 13960296     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2005.05002.x     Document Type: Review

References (38)

1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics. CA Cancer J Clin 2000: 50: 7-33.
2. Sheil AG. Development of malignancy following renal transplantation in Australia and New Zealand. Transplant Proc 1992: 24: 1275-1279.
3. Edwards NM, Rajasinghe HA, John R, Chen JM, Itescu S, Mancini DM. Cardiac transplantation in over 1000 patients: a single institution experience from Columbia University. Clin Transplan 1999: 249-261.
4. Penn I. Post-transplant malignancy: the role of immunosuppression. Drug Saf 2000: 23: 101-113.
5. Moloney FJ et al. Maintenance versus reduction of immunosuppression in renal transplant recipients with aggressive squamous cell carcinomas. Derm Surg 2004: 30 (4): 674-678.
6. Hartevelt MM, Bavinck JN, Kootte AM, Vermeer BJ, Vandenbroucke JP. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation 1990: 49: 506-509.
7. Berg D, Otley C. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002: 47: 1-17.
8. Jensen P, Hansen S, Moller B et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999: 40: 177-186.
9. Bouwes Bavinck JN, Hardie DR, Green A et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation 1996: 61: 715-721.
10. Lampros TD, Cobanoglu A, Parker P, Ratkovec R, Norman DJ, Hershberger R. Squamous and basal cell carcinomas in heart transplant recipients. J Heart Lung Transplant 1998: 17: 586-591.
11. Euvrard S, Kanitkas J, Pouteil-Noble C et al. Aggressive squamous cell carcinomas in organ transplant recipients. Transplant Proc 1995: 27: 1767-1768.
12. Carucci JA, Martinez JC, Zeitouni N et al. In-transit metastasis from primary cutaneous squamous cell carcinoma in organ transplant recipients and nonimmunosuppressed patients: clinical characteristics, management and outcome in a series of 21 patients. Derm Surg 2004: 30 (4): 651-655.
13. Stasko T, Brown MD, Carucci J et al. Guidelines for the management of squamous cell carcinoma in organ transplant recipients. Derm Surg 2004: 30 (4): 642-650.
14. Ferrandiz C, Fuente MJ, Ribera M et al. Epidermal dysplasia and neoplasia in kidney transplant recipients. J Am Acad Dermatol 1995: 33: 590-596.
15. Ramsay HM, Fryer AA, Reece S, Smith AG, Harden PN. Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients. Am J Kidney Dis 2000: 36: 167-176.
16. Penn I. Malignant melanoma in organ allograft recipients. Transplantation 1996: 61: 274-278.
17. Bavnick JN, DeBoer A, Vermeer BJ et al. Sunlight, keratotic lesions and skin cancer in renal transplant recipients. Br J Dermatol 1993: 129: 242-249.
18. Jensen P, Hansen S, Moller B, Leivestad T, Pfeffer P, Fauchald P. Are renal transplant recipients on CsA-based immunosuppressive regimens more likely to develop skin cancer than those on azathioprine and prednisolone? Transplant Proc 1999: 31: 1120.
19. Harwood CA, Surentheran T, McGregor JM et al. Human papillomavirus infection and nonmelanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol 2000: 61: 289-297.
20. Berkhout RJM, Bouwes-Bavinck JN, ter Schegget J. Persistence of human papillomavirus DNA in benign and (pre) malignant skin lesions from renal transplant recipients. J Clin Microbiol 2000: 38: 2087-2096.
21. De Villiers EM, Lavergne D, McLaren KM, Benton EC. Prevailing papillomavirus types in nonmelanoma carcinomas of the skin in renal allograft recipients. Int J Cancer 1997: 73: 356-361.
22. Meyer T, Arndt R, Christophers E, Nindl I, Stockfleth E. Importance of human papillomaviruses for the development of skin cancer. Cancer Detect Prev 2001: 25: 533-547.
23. Shamanin V, zur Hausen H, Lavergne D et al. Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J Natl Cancer Inst 1996: 88: 802-811.
24. Stockfleth E, Nindl I. Wolfram et al. Human papillomaviruses in transplant associated skin cancers. Dermatologic Surg 2004: 30: 604-609.
25. Adamson R, Obispo E, Dychter S et al. High incidence and clinical course of aggressive skin cancer in heart transplant recipients: a single-center study. Transplant Proc 1996: 1124-1126.
26. London NJ, Farmery SM, Will EJ, Davison AM, Lodge JP. Risk of neoplasia in renal transplant patients. Lancet 1995: 346: 403-406.
27. Roeger LS, Sheil AGR, Disney APS, Mathew TH, Amiss N. Risk factors associated with the development of squamous cell carcinomas in immunosuppressed renal transplant recipients. Clin Transplant 1992: 6: 202-211.
28. Douds AC, Mellotte GJ, Morgan SH. Fatal Merkel-cell tumour (cutaneous neuroendocrine carcinoma) complicating renal transplantation. Nephrol Dial Transplant 1995: 10: 2436-2438.
29. Hafner J, Kunzi W, Weinreich T. Malignant fibrous histiocytoma and atypical fibroxanthoma in renal transplant recipients. Dermatology 1999: 198: 29-32.
30. Wehril BM, Janzen DL, Shokeir O, Masri BA, Byrne SK, O'Connell JX. Epitheliod angiosarcoma arising in surgically constructed arteriovenous fistula: a rare complication of chronic immunosuppression in the setting of renal transplantation. Am J Surg Pathol 1998: 22: 1154-1159.
31. Kibe Y, Kishimoto S, Katoh N, Yasuno H, Yasumura T, Oka T. Angiosarcoma of the scalp associated with renal transplantation. Br J Dermatol 1997: 136: 752-756.
32. Robinson JR, Rigel DS. Sun protection attitudes and behaviors of solid-organ transplant recipients. Derm Surg 2004: 30 (4): 610-615.
33. Otley CC. Organization of a specialty clinic to optimize the care of organ transplant recipients at risk for skin cancer. Dermatologic Surg 2000: 26: 709-712.
34. Christenson LJ, Geusau A, Ferrandiz C et al. Specialty clinics for the dermatologic care of solid-organ transplant recipients. Derm Surg 2004: 30 (4): 598-603.
35. Boyd AS. Histologic features of actinic keratoses in solid organ transplant recipients and healthy controls. J Am Acad Dermatol 2001: 45: 217-221.
36. Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol 1992: 26: 976-990.
37. Altinyollar H, Berberoglu U, Celen O. Lymphatic mapping and sentinel node biopsy in squamous cell carcinoma of the lower lip. Eur J Surg Oncol 2002: 28: 72-74.
38. Bavinck JN, Tieben LM, Van der Woude FJ et al. Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study. J Clin Oncol 1995: 13: 1933-1938.